2 hrs ago | Drug Researcher
Pfizer signs up Biologics Inc as cancer drug distributor
The agreement - financial terms of which were not made public - covers the distribution of Pfizer's renal cell carcinoma treatment Inlyta , which was approved by the US Food and Drug Administration late last month.
Risk of fatal side effects raised by three cancer drugs
According to a new analysis led by scientists at Dana-Farber Cancer Institute treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects.
Kidney cancer is cancer that originates in the kidneys. Your kidneys are two bean-shaped organs, each about the size of your fist.
NJOP to Honor Dr. David B. Samadi for Exceptional Commitment and Contributions to the Organization
The dinner will honor Dr. David B. Samadi , an outstanding individual whose invaluable contributions have enabled NJOP to provide thousands of Jews with a greater connection to Judaism.
50 years of yours, mine and ours
In what was a second marriage for both, Faye and George Dettman have enjoyed 50 years of wedded bliss.
Pfizer Selects Biologics, Inc. as Limited Distribution Network Partner
Biologics, Inc., an integrated oncology services company has been selected as a Limited Distribution Network partner for Pfizer's Inlyta which was approved by the FDA on January 27, 2012.
The Apothecary Shops Reaches Agreement with Pfizer to Distribute Inlyta
PHOENIX, Feb. 8, 2012 /PRNewswire-iReach/ -- The Apothecary Shops Specialty Pharmacies has received distribution rights from pharmaceutical manufacturer Pfizer for its new drug Inlyta , and will begin to provide this new drug to patients immediately.
Three 'Targeted' Cancer Drugs Raise Risk of Fatal Side Effects
Newswise - BOSTON--Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute.
3 'targeted' cancer drugs raise risk of fatal side effects
Toni Choueiri, MD, and colleagues report they have found that treatment with three "targeted " cancer drugs has been linked to a slightly elevated chance of fatal side effects.
Benefit dinner to be held tonight for Bay City man with brain and kidney cancer
A benefit soup dinner is scheduled today for Randy Lee, a 54-year old father and husband who was recently diagnosed with cancer.
Agenus to Present at Bio Ceo & Investor Conference
Agenus Inc. , a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be presenting at the 14th Annual BIO CEO & Investor Conference, which will be held at the Waldorf=Astoria Hotel in New York City.
Family of Emaleigh Blankenship thanks community for support of 2-year-old battling rare syndrome
The family of Emaleigh Blankenship thanks the community for its support during the 2-year-old girl's medical struggles.
Mega Lok Adalat for gas-affected victims
Bhopal, Feb 4 : A mega Lok Adalat for Bhopal gas tragedy-affected people was today inaugurated by Madhya Pradesh's Bhopal Gas Tragedy Relief and Rehabilitation Minister Babulal Gaur here today.
Cabozantinib Shows Encouraging Activity in Heavily Pretreated...
SOUTH SAN FRANCISCO, Calif.-- --Exelixis, Inc. today reported preliminary data from a cohort of heavily pretreated patients with metastatic refractory renal cell carcinoma participating in an ongoing phase 1b trial of cabozantinib.
Professor documents cancer battle in online videos
A new drug to fight bladder cancer, developed by Nobel Prize-winner, Dr. Andrew Schally of the University of Miami, has given hope to the first patient in a clinical trial.
FDA clears drug for advanced kidney cancer
Patients with hard-to-treat kidney cancer that has spread to other parts of the body gained a new drug option Friday, after federal regulators approved a twice-a-day pill from Pfizer for the disease.
Saint Josephs uses robot, infrared technology to remove tumor
Certified Nurse Anesthetist Dominick Martorana prepares the fluorescent green dye for injecting into the patient to aid in the removal of a kidney tumor Tuesday at Ministry Saint Joseph's Hospital in Marshfield.
Monthly Roundup - January 2012
Amylin Pharmaceuticals received FDA-approval of Bydureon , a once-a-week, 2 mg injection used in conjunction with diet and exercise to improve glycemic control in type 2 diabetics .
Kidney Cancer? There's a Drug for That
The way to make money in biotech is to find companies going after unmet needs . The bar is lower for an approval and sales are easier without any competition.
Drug approved to treat cystic fibrosis' root cause
The first drug that treats the root cause of cystic fibrosis won approval Tuesday, offering a life-changing treatment for a handful of patients with the deadly illness and broader hope for thousands more patients with the inherited disease.
Also on Topix